Evidence map›Paper›PMID 35550593›Full record

ArticleCommunications biology2022

Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice.

Yuxing Xia, Stefan Prokop, Brach M Bell, Kimberly-Marie M Gorion, Cara L Croft, Lith Nasif, Guilian Xu, Cara J Riffe, Alyssa N Manaois, Kevin H Strang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Yuxing XiaDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.ORCID 0000-0002-8415-8256
Stefan ProkopCenter for Translational Research in Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Brach M BellDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Kimberly-Marie M GorionDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Cara L CroftDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.ORCID 0000-0001-7969-5084
Lith NasifDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.ORCID 0000-0001-5515-6115
Guilian XuDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Cara J RiffeDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Alyssa N ManaoisDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Kevin H StrangDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Stephan S QuintinDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.ORCID 0000-0002-5880-8470
Giavanna PaternoDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Malú Gámez TanseyDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.ORCID 0000-0002-1719-4708
David R BorcheltDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Todd E GoldeDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Benoit I GiassonDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA. bgiasson@ufl.edu.ORCID 0000-0003-2992-4234
University of Florida · US

Funding

Investigating Mechanisms of Neurodegeneration in Transgenic Mouse Models of TauopathiesF30AG067673 · NIA · UNIVERSITY OF FLORIDA · PI XIA, YUXING · 2021 to 2023
$110k
NIA NIH HHS F30 AG067673
6 · The paper itself

Abstract

Pathological tau inclusions are neuropathologic hallmarks of many neurodegenerative diseases. We generated and characterized a transgenic mouse model expressing pathogenic human tau with S320F and P301S aggregating mutations (SPAM) at transgene levels below endogenous mouse tau protein levels. This mouse model develops a predictable temporal progression of tau pathology in the brain with biochemical and ultrastructural properties akin to authentic tau inclusions. Surprisingly, pathogenic human tau extensively recruited endogenous mouse tau into insoluble aggregates. Despite the early onset and rapid progressive nature of tau pathology, major neuroinflammatory and transcriptional changes were only detectable at later time points. Moreover, tau SPAM mice are the first model to develop loss of enteric neurons due to tau accumulation resulting in a lethal phenotype. With moderate transgene expression, rapidly progressing tau pathology, and a highly predictable lethal phenotype, the tau SPAM model reveals new associations of tau neurotoxicity in the brain and intestinal tract.

Indexed as

Braintau ProteinsAnimalsDisease Models, AnimalHumansMiceMice, TransgenicMutationNeuronsMAPT protein, humantau Proteins

Identifiers

PMID35550593
PMCPMC9098443
OpenAlexW4280525197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.